Your browser doesn't support javascript.
loading
Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies.
Mitsiades, Nicholas; Pazaitou-Panayiotou, Kalliopi; Aronis, Konstantinos N; Moon, Hyun-Seuk; Chamberland, John P; Liu, Xiaowen; Diakopoulos, Kalliope N; Kyttaris, Vasileios; Panagiotou, Vasiliki; Mylvaganam, Geetha; Tseleni-Balafouta, Sofia; Mantzoros, Christos S.
Afiliação
  • Mitsiades N; Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Clin Endocrinol Metab ; 96(12): E2023-8, 2011 Dec.
Article em En | MEDLINE | ID: mdl-21937620
ABSTRACT
CONTEXT Circulating adiponectin has been inversely associated with risk for several malignancies. Its association with thyroid cancer has not yet been evaluated. OBJECTIVE/

METHODS:

We measured circulating adiponectin levels in 175 thyroid carcinoma patients and 107 controls. We also examined the expression of adiponectin receptors (AdipoR1 and AdipoR2) using immunohistochemistry in 82 thyroid carcinoma tissues and using RT-qPCR in 40 human thyroid carcinoma tissues (32 papillary, six follicular/Hurthle, one anaplastic, one medullary), four normal human thyroid tissue specimens, and the BHP7 and SW579 thyroid cancer cell lines. We then utilized these thyroid cancer cell lines to investigate whether adiponectin could directly regulate cell cycle or apoptosis.

RESULTS:

Thyroid cancer patients had lower circulating adiponectin levels than controls (17.00 ± 6.32 vs. 19.26 ± 6.28 µg/ml; P < 0.001). Subjects in the highest tertile of circulating adiponectin concentrations had significantly lower odds of developing any type of thyroid carcinoma (odds ratio = 0.29; 95% confidence interval, 0.16-0.55), or papillary thyroid carcinoma (odds ratio = 0.27; 95% confidence interval, 0.14-0.55), before and after adjustment for potential confounders. Both thyroid carcinoma cell lines and tissues expressed AdipoR1 and AdipoR2. Recombinant adiponectin did not exert a clinically significant direct effect on cell cycle, proliferation, or apoptosis in thyroid cancer cell lines in vitro.

CONCLUSIONS:

Circulating adiponectin is independently and inversely associated with the risk of thyroid cancer. Human thyroid carcinomas and cell lines express adiponectin receptors. However, in the absence of a major direct effect of adiponectin on thyroid cancer cell lines in vitro, the negative association observed herein may be attributed to the metabolic effects of adiponectin.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma Papilar / Adenocarcinoma Folicular / Adiponectina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma Papilar / Adenocarcinoma Folicular / Adiponectina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2011 Tipo de documento: Article